WHO approves Ranbaxy's drug Abacavir

Pharma major Ranbaxy said the World Health Organisation has approved its anti-retro viral drug Abacavir 300 mg tablets in pre-qualification list.

By PTI | Aug 01, 2008, 01.44 PM IST

NEW DELHI: Pharma major Ranbaxy on Friday said the World Health Organisation has approved its anti-retro viral drug Abacavir 300 mg tablets in pre-qualification list.

Anti-retro viral drugs are used for the treatment of infections by retroviruses, primarily HIV.

Abacavir will be manufactured at Ranbaxy's WHO pre-qualified manufacturing site at Paonta Sahib in Himachal Pradesh, the drug maker said in a statement.

With this approval, the pharma company has 18 anti-retro viral drugs in the WHO pre-qualification list.

Start a SIP with as low as ₹500 with ET Money App!